These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 19557982)

  • 1. Mitral regurgitation reduces systemic coagulation activity in rheumatic heart disease: using fibrin D-dimer as a biomarker of thrombogenesis.
    Tay KH; Khoo CW; Lip GY
    J Heart Valve Dis; 2009 May; 18(3):276-7. PubMed ID: 19557982
    [No Abstract]   [Full Text] [Related]  

  • 2. Mitral regurgitation reduces systemic coagulation activity in patients with rheumatic heart disease.
    Cevik C; Otahbachi M; Nugent K; Ozkan M
    J Heart Valve Dis; 2009 May; 18(3):278-83. PubMed ID: 19557983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrin D-dimer levels and thromboembolic events in patients with atrial fibrillation.
    Watson T; Shantsila E; Lip GY
    Int J Cardiol; 2007 Aug; 120(1):123-4; author reply 125-6. PubMed ID: 17055595
    [No Abstract]   [Full Text] [Related]  

  • 4. D-dimer levels in combination with clinical risk factors can effectively predict subsequent thromboembolic events in patients with atrial fibrillation during oral anticoagulant therapy.
    Sadanaga T; Kohsaka S; Ogawa S
    Cardiology; 2010; 117(1):31-6. PubMed ID: 20881392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Predictive value of coagulative molecular markers for thromboembolism in patients with nonvalvular atrial fibrillation: prospective five-year follow-up study].
    Enta K; Iwade K; Aosaki M; Uchida T; Kasanuki H
    J Cardiol; 2004 Dec; 44(6):223-32. PubMed ID: 15638220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of mitral regurgitation on coagulation activity in atrial fibrillation.
    Fukazawa H; Yamamoto K; Ikeda U; Shimada K
    Am J Cardiol; 1998 Jan; 81(1):93-6. PubMed ID: 9462616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Blood rheology and central hemodynamics in rheumatic mitral valve diseases].
    Murashko VV; Dzhanashiia PKh; Shardanov NA; Kaĭdash AN; Khurtsilava SG
    Revmatologiia (Mosk); 1983; (2):26-9. PubMed ID: 6353510
    [No Abstract]   [Full Text] [Related]  

  • 8. Fibrin D-dimer and cardiovascular risk.
    Lowe GD
    Semin Vasc Med; 2005 Nov; 5(4):387-98. PubMed ID: 16302161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D-dimers in atrial fibrillation: a further step in risk stratification of thrombo-embolism?
    Cohen A; Ederhy S; Meuleman C; Di Angelantonio E; Dufaitre G; Boccara F
    Eur Heart J; 2007 Sep; 28(18):2179-80. PubMed ID: 17716992
    [No Abstract]   [Full Text] [Related]  

  • 10. Thrombogenesis in mitral regurgitation and aortic stenosis.
    Lip GY; Rumley A; Dunn FG; Lowe GD
    Angiology; 1996 Dec; 47(12):1117-25. PubMed ID: 8956663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet survival in patients with rheumatic heart disease.
    Steele PP; Weily HS; Davies H; Genton E
    N Engl J Med; 1974 Mar; 290(10):537-9. PubMed ID: 4811098
    [No Abstract]   [Full Text] [Related]  

  • 12. D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
    Ay C; Vormittag R; Dunkler D; Simanek R; Chiriac AL; Drach J; Quehenberger P; Wagner O; Zielinski C; Pabinger I
    J Clin Oncol; 2009 Sep; 27(25):4124-9. PubMed ID: 19636003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A very elevated D-dimer level may potentially be useful.
    Heath R; Horton S; Martlew V; Thachil J
    Eur J Intern Med; 2013 Mar; 24(2):e19-20. PubMed ID: 23044170
    [No Abstract]   [Full Text] [Related]  

  • 14. Levels of plasma fibrinogen and D-dimer in subjects with white-coat hypertension.
    Coban E; Ozdoğan M; Akçit F
    J Hum Hypertens; 2004 Apr; 18(4):291-2. PubMed ID: 15037880
    [No Abstract]   [Full Text] [Related]  

  • 15. Proper observation of patient-related factors is an important determinant in the use of the D-dimer test for exclusion of venous thromboembolism in the ED.
    Houdijk WP
    Am J Emerg Med; 2007 Feb; 25(2):255-6. PubMed ID: 17276847
    [No Abstract]   [Full Text] [Related]  

  • 16. Reply to Proper observation of patient related factors is an important determinant in the utility of the D-dimer test for exclusion of venous thromboembolism in the ED.
    Ray P
    Am J Emerg Med; 2007 May; 25(4):485-6. PubMed ID: 17499677
    [No Abstract]   [Full Text] [Related]  

  • 17. [Predication of hemodynamic changes of rheumatic heart disease with P wave of electrocardiogram].
    Wang C; Xie Z; Cao M; Mao D; Li M
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(5):462, 464. PubMed ID: 10073038
    [No Abstract]   [Full Text] [Related]  

  • 18. [Soluble fibrin monomer complexes in thromboembolism].
    Gryglik J
    Przegl Lek; 1982 Sep; 39(8):551-3. PubMed ID: 6753042
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiac troponin I and plasma D-dimer are related to proximal and bilateral extension of clots and right cardiac dysfunction in patients with pulmonary embolism.
    Masotti L; Antonelli F; Venturini E; Landini G
    J Intern Med; 2007 Nov; 262(5):588-9. PubMed ID: 17949367
    [No Abstract]   [Full Text] [Related]  

  • 20. [Characteristics of the acid-base equilibrium of the blood in pregnant women with mitral heart disease of rheumatic origin].
    Nikolaeva ND
    Vopr Okhr Materin Det; 1971 Jan; 16(1):69-72. PubMed ID: 5575093
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.